Rights and permissions
About this article
Cite this article
Etoposide 3- or 21-day regimen QOL effect in SCLC. Inpharma Wkly. 1343, 7 (2002). https://doi.org/10.2165/00128413-200213430-00013
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200213430-00013